Page last updated: 2024-11-06

mitomycin and Brucellosis

mitomycin has been researched along with Brucellosis in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.

Research Excerpts

ExcerptRelevanceReference
"Brucellosis is a worldwide bacterial zoonosis disease."1.56Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection. ( Azizi, M; Bouzari, S; Fasihi-Ramandi, M; Sadeghi, Z, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sadeghi, Z1
Fasihi-Ramandi, M1
Azizi, M1
Bouzari, S1

Other Studies

1 other study available for mitomycin and Brucellosis

ArticleYear
Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Journal of biotechnology, 2020, Feb-20, Volume: 310

    Topics: Animals; Antigens, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Brucella abortus; Bruc

2020